Simultaneous disruption of both AdipoR1 and AdipoR2 abolished adiponectin binding and actions, resulting in increased liver triglyceride content, inflammation and oxidative stress in adipose tissue, and consequent insulin resistance and glucose intolerance [53]. The gene discussed is ADIPOQ; the disease is Glucose intolerance.